One of the greatest challenges retail investors face is figuring out which stock is undervalued and finding the right entry point to buy that stock. However, history shows that these are the points where investors falter most often.Stocktwits recently conducted a poll asking users on the platform which stock in the robotics sector has the most upside in 2025. Of the three names—Richtech Robotics Inc. (RR), Serve Robotics Inc. (SERV), and Microbot Medical Inc. (MBOT)—retail investors chose to side with RR, which has witnessed the most downside over the last year.<figure class="image"><img style="aspect-ratio:1320/766;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/RR_poll_and_results_abc2021e3e.png" alt="RR poll and results.png" width="1320" height="766"></figure>Richtech Robotics lost nearly 59% of its market capitalization during this period, compared to SERV's almost 28% loss and MBOT's 43% gain.Even from a year-to-date perspective, RR stock has gained just about 14%, SERV has risen over 27%, and MBOT has increased over 80%. This leaves more room for RR to pare its losses after last year’s disappointing performance.Interestingly, it appears retail investors are betting on the stock that seems to be undervalued due to its price movement. The question is whether a significant decline in stock price indicates an equally lucrative potential for a reversion to the mean or a persisting weakness in the fundamentals.Another notable metric appears to be the short interest on these stocks. According to KoyFin, RR has the lowest short interest among the three names of about 3.1% while MBOT has a short interest of about 3.4% and SERV has a short interest of about 5.7%. Although the numbers do not seem significant, the needle still points toward RR as the best choice.Investor perception, too, is a crucial deciding factor. While MBOT stock appears to be the least undervalued of the three stocks, SERV shares have drawn some negative reactions recently. The company announced $80 million worth of direct offering, drawing negative reactions from investors.This development also favors RR as the stock with the most upside this year.However, markets never cease to surprise, and with 2025 just two weeks old, investors will have plenty of time to assess how the evolving macro picture affected these companies' fundamentals.It will also be interesting to analyze whether the much-talked-about mean reversion worked for RR stock.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/gbtg-stock-falls-on-dojs-lawsuit/chGWtrMRZC">Global Business Travel Group Stock Falls On DOJ’s Lawsuit To Block Acquisition Of CWT Holdings</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market data with uptrend vector | Illustration Source: Getty Images

Stocktwits Poll: Retail Investors Bet RR Stock Will Have Most Upside In 2025 Among Robotics Players

Richtech Robotics lost nearly 59% of its market capitalization in the period, compared to a nearly 28% loss posted by SERV and a 43% gain registered by MBOT during the period.

Equity

Richtech Robotics lost nearly 59% of its market capitalization in the period, compared to SERV's nearly 28% loss and MBOT's 43% gain.

Shares of Iovance Biotherapeutics have dropped over 17% so far this week, on course to mark their worst weekly decline since mid-November 2024.&nbsp;The selloff aligns with broader pressure on small-cap stocks within the Russell 2000 index, which is sliding into correction territory as fears over prolonged higher interest rates grip the market.Macroeconomic concerns have intensified following robust U.S. jobs data, showing accelerating job growth and a lower unemployment rate of 4.1% in December.&nbsp;Small and mid-cap companies, like Iovance, are particularly sensitive to rate dynamics due to their reliance on borrowing compared to larger companies.<figure class="image"><img style="aspect-ratio:1314/1036;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/IOVA_poll_sentiment_and_message_volume_Jan_10_95fa61f76a.png" alt="IOVA poll sentiment and message volume Jan 10.png" width="1314" height="1036"><figcaption>IOVA poll sentiment and message volume Jan 10 as of 2 pm ET | source: Stocktwits</figcaption></figure>Despite the macro-driven plunge, sentiment for Iovance has turned ‘extremely bullish’ on Stocktwits, with the stock becoming one of the platform’s top three trending tickers on Friday afternoon.&nbsp;Many retail investors see the selloff as overdone, drawing attention to the company’s promising medical pipeline and proprietary technology.<stembedurl>https://stocktwits.com/thebullofwallst/message/599572619</stembedurl><stembedurl>https://stocktwits.com/parsnips/message/599576937</stembedurl>Some also speculated on the possibility of acquisition interest, citing Vertex Pharmaceuticals’ $4.9 billion premium buyout of Alpine Immune Sciences in 2024 as a precedent.&nbsp;<stembedurl>https://stocktwits.com/AngusMacbeth/message/599584221</stembedurl>In November, Iovance CEO Frederick Vogt highlighted the strong U.S. launch of Amtagvi for advanced melanoma and its growing demand through an expanding network of authorized treatment centers. "As a fully integrated company, Iovance is well positioned to remain the global leader in innovating, developing, and delivering current and future generations of TIL cell therapy for patients with cancer," he added.Tumor-infiltrating lymphocyte (TIL) therapy is an innovative, patient-specific approach that uses T-lymphocytes derived from a patient’s tumor to combat cancer cells.Retail optimism about TIL therapy remains high, with 67% of respondents in a Stocktwits poll calling it a “game-changer” in cancer treatment.&nbsp;The therapy this week gained visibility as MedStar Georgetown University Hospital became the first in the Washington, D.C., area to offer it for metastatic melanoma.Iovance’s retail following has grown by 65% over the past year, even as the stock has shed more than 30% during the same period.The company’s stock remains a battleground for investors, with short interest hovering at 19.5%.&nbsp;While macroeconomic challenges weigh on small caps, retail investors remain steadfast in their optimism, betting on TIL therapy’s transformative potential to reshape cancer treatment.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Illustration depicting tumour infiltrating lymphocyte (TIL) therapy for cancer treatment. During TIL therapy, T-cells (blue) that recognise tumour cells (red) are obtained from a patient. | Image source: Getty Images

Cancer Drug Maker Iovance Tumbles Toward Worst Week Since November, But Retail Feels Macro Selloff Overblown

In November, Iovance CEO Frederick Vogt highlighted the strong U.S. launch of Amtagvi for advanced melanoma and its growing demand through an expanding network of authorized treatment centers.

Iovance Stock Tumbles On Macro Concerns, But Retail Stays Bullish On TIL Cancer Therapy Potential

California utility PG&amp;E Corp. (PCG) shares fell by more than 10% in mid-day trade on Friday, hitting their lowest levels since July, as the wildfires in Los Angeles continued to spread.Moody's insurance analysts dub the blaze 'among the most costly wildfires' in California history.“It will take weeks or months to determine the magnitude of the insured damages, but the Los Angeles wildfires are likely among the most costly wildfires in the state's history,” analysts said in a note Thursday.Authorities haven’t determined the cause of the Eaton wildfire or the other major blazes burning in Los Angeles. However, reports indicate that the wildfires are not located in PG&amp;E’s service territory.However, PG&amp;E has a history of wildfire-related liabilities, with over $30 billion in legal claims tied to previous fires that led to its 2019 Chapter 11 bankruptcy —&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.hbs.edu/faculty/Pages/item.aspx?num=59284">termed</a> "the first climate change bankruptcy" by Harvard researchers.&nbsp;The state subsequently established a $21-billion utility fire insurance fund to shield California's investor-owned utilities from catastrophic fire-related financial risks.<figure class="image"><img style="aspect-ratio:1293/287;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_01_10_134209_8a4d499b04.png" alt="Screenshot 2025-01-10 134209.png" width="1293" height="287"><figcaption>PG&amp;E Corp. Sentiment and Message Volume on Jan.10 as of 1:25 p.m. ET | Source: Stocktwits</figcaption></figure>On Stocktwits, retail sentiment dimmed to ‘bullish’ from ‘extremely bullish’ a day ago as chatter remained at ‘extremely high’ levels.&nbsp;Some users pointed out that the current wildfires were not in PG&amp;E’s territory, while other highlighted the opportunity to buy the stock at a discount.<stembedurl>https://stocktwits.com/thewalkingdead/message/599565747</stembedurl><stembedurl>https://stocktwits.com/Damian125/message/599536265</stembedurl><stembedurl>https://stocktwits.com/leomega/message/599555855</stembedurl>PG&amp;E stock is now down 4% over the past year, with a 13% decline since the onset of the wildfires.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/snowflake-stock-rises-on-barclays-upgrade/chGWuuZRZ6">Snowflake Stock Climbs on Barclays Upgrade, But Retail Stays Skeptical</a>

PG&E Stock Sinks To 6-Month Low As LA Wildfires Likely Among California’s Costliest, But Retail Shows No Panic 

PG&E has a history of wildfire-related liabilities, with over $30 billion in legal claims tied to previous fires that led to its 2019 Chapter 11 bankruptcy.

Shares of Critical Metals Corp. (CRML) surged nearly 20% in mid-day trade on Friday as investors reacted to Barclays Plc. increasing its holdings&nbsp;threefold.According to 13F filings with the U.S. Securities and Exchange Commission&nbsp;(SEC), Barclays owned 10,473 shares of Critical Metals at the end of Q3, rising from 2,477 shares in Q2. Barclays’ holdings are now worth $77,000.In addition, JPMorgan Chase &amp; Co. more than doubled its holdings, now worth $90,000.Cantor Fitzgerald, LP., and Polar Asset Management Partners Inc. continue to be Critical Metals' largest institutional shareholders, with 1.25 million and 730,000 shares, respectively.The increase in holdings comes after the company appointed new CFO Steven R Parkes in December and announced a transition of its board.&nbsp;The Australia-headquartered company also confirmed that it had found high-grade rare earth elements at its Tanbreez project in Greenland.“On the heels of China’s recent decision to restrict the exports of certain rare earth materials, Critical Metals&nbsp;Corp. is poised to support Western countries with materials essential for producing clean energy applications and supporting their defense industries,” said CEO Tony Sage.Retail sentiment on Stocktwits was in the ‘extremely bullish’ (97/100) zone.<figure class="image"><img style="aspect-ratio:652/151;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_01_10_225142_57493bd5e4.jpg" alt="CRML retail sentiment" width="652" height="151"><figcaption>CRML sentiment and message volume January 10, 2025, as of 1:30 pm ET | Source: Stocktwits</figcaption></figure>While one user underscored their bullish outlook on the <a href="https://stocktwits.com/symbol/CRML">Critical Metals stock</a>, they also cautioned about volatility.<stembedurl>https://stocktwits.com/_www_larval_com_/message/599548469</stembedurl>Despite Friday’s surge, Critical Metals' stock price has fallen by more than 30% in the past six months, while its one-year performance is worse, with a decline of over 50%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/intel-stock-hits-5-month-low-as-mizuho-lowers-price-target-citi-stays-neutral-as-investors-await-pat-gelsinger-replacement/chGWszjRZU">Intel Stock Hits 5-Month Low As Mizuho Lowers Price Target, Citi Stays 'Neutral' As Investors Await Pat Gelsinger's Replacement: Retail Turns Bullish</a>

Critical Metals Stock Skyrockets As Barclays Increases Holdings By 3X: Retail Turns Extremely Bullish

Critical Metals confirmed a month ago that it found high-grade rare earth elements in its Tanbreez project in Greenland.

Snowflake Inc. (SNOW) stock rose over 1% in mid-day trading on Friday following an upgrade from Barclays, which shifted its rating to ‘Overweight’ from ‘Equal Weight’ while maintaining a price target of $190.Barclays highlighted Snowflake’s evolving AI-driven product momentum under its new management, projecting significant growth contributions from newly matured offerings in fiscal 2026.The brokerage emphasized that Snowflake’s focus on AI trends and accelerated product velocity positions it for meaningful progress this year, according to TheFly.This comes after Deutsche Bank raised the firm's price target on Snowflake to $210 from $190 on Wednesday and kept a ‘Buy’ rating on the shares, citing that the software will outperform in 2025.&nbsp;It anticipates improving fundamentals and AI-driven demand trends to support software sector growth to offset "slow-but-ramping" generative AI adoption, elevated capex, and an ongoing scaling laws debate.Wells Fargo also upgraded the stock to ‘Overweight’ from ‘Equal Weight’ earlier this week, increasing its price target to $200 from $150.Wells Fargo noted Snowflake’s favorable position for 2025, citing healthier budget growth among enterprise clients and a budding product cycle. However, the firm cautioned about potential volatility, reminiscent of early 2024 pullbacks in the software sector.<figure class="image"><img style="aspect-ratio:1289/301;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_01_10_124731_365c146385.png" alt="Screenshot 2025-01-10 124731.png" width="1289" height="301"><figcaption>Snowflake Inc. Sentiment and Message Volume on Jan.10 as of 12:45 p.m. ET | Source: Stocktwits</figcaption></figure>However, retail sentiment on Stocktwits was ‘bearish’ even as chatter increased to ‘high’ from ‘normal’ levels.&nbsp;Some users pointed to bearish technical patterns, like an “inverse cup and handle,” signaling potential further declines.<stembedurl>https://stocktwits.com/APLUSINVESTING/message/599574024</stembedurl>Others expressed interest in buying shares if prices dip further.<stembedurl>https://stocktwits.com/Olddrache/message/599558303</stembedurl>However, one user pointed to the company’s turnaround over the last quarter.&nbsp;<stembedurl>https://stocktwits.com/srini99/message/599562998</stembedurl>Snowflake’s stock has declined over 17% in the past year, weighed down by slowing growth rates and increasing competition from cloud-neutral software providers and public cloud giants.&nbsp;The company also faced legal investigations into potential governance lapses during that time, stemming from a 28% stock drop in 2022 following reduced revenue forecasts.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/wolfspeed-stock-hits-27-year-low-amid-semiconductor-sector-sell-off/chGWtZfRZz">Retail Sentiment On Wolfspeed Stock Remains Bullish Despite Historic Drop To 27-Year Low</a>

POLAND - 2023/12/01: In this photo illustration, a Snowflake logo is displayed on a smartphone with stock market percentages in the background. (Photo Illustration by Omar Marques/SOPA Images/LightRocket via Getty Images)

Snowflake Stock Climbs on Barclays Upgrade, But Retail Stays Skeptical

Barclays’ upgrade, highlighting Snowflake’s focus on AI trends and accelerated product development, follows Deutsche Bank’s price target increase and Wells Fargo’s upgrade earlier this week.

Shares of Global Business Travel Group Inc. (Amex GBT) fell over 3% on Friday after the Justice Department (DOJ) <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.justice.gov/opa/pr/justice-department-sues-block-global-business-travel-groups-proposed-acquisition-cwt">filed</a> a civil antitrust lawsuit to stop the firm, the largest business travel management company in the world, from acquiring its rival, CWT Holdings LLC (CWT).CWT is the third-largest business travel management company in the world.In March 2024, Amex GBT announced its intent to acquire CWT in a $570 million deal that was to be funded by a combination of stock and cash and was expected to close in the second half of 2024.DOJ’s lawsuit alleges that the proposed transaction would impact competition for business travel management services to U.S. global and multinational businesses. Notably, this is Amex GBT’s fifth acquisition of another travel management company since 2018.Acting Assistant Attorney General Doha Mekki said the acquisition is the latest in a series of deals done by Amex GBT that will further consolidate an already consolidated market."American businesses will face the consequences, seeing higher prices, less innovation, and fewer choices,” Mekki said.The DOJ explained that both firms compete fiercely to provide travel management services for large businesses and those with complex travel needs. Amex GBT had recently lost several significant bid opportunities for large business customers to CWT after the latter began pursuing new and innovative strategies to improve service and reduce prices.“If Amex GBT is permitted to acquire CWT, this intense competition would be lost, risking higher prices, less innovation, and fewer choices,” the DOJ said.Although Amex GBT operates as a separate company, it is noteworthy that American Express holds a minority interest in the firm.Interestingly, American Express shares traded down over 2% on Friday afternoon following the lawsuit announcement but retail sentiment surrounding the stock was trending in the ‘bullish’ territory (67/100) compared to ‘bearish’ a day ago. The move was accompanied by ‘high’ message volume.<figure class="image"><img style="aspect-ratio:1860/428;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_01_10_at_12_40_33_PM_645d5c0824.png" alt="AXP’s Sentiment Meter and Message Volume as of 12:02 p.m. ET on Jan. 10, 2025 | Source: Stocktwits" width="1860" height="428"><figcaption>AXP’s Sentiment Meter and Message Volume as of 12:02 p.m. ET on Jan. 10, 2025 | Source: Stocktwits</figcaption></figure>Earlier this week, Truist initiated coverage of American Express with a ‘Buy’ rating and a $350 price target.<a href="https://stocktwits.com/symbol/AXP">American Express shares</a> have risen over 59% over the past year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/delta-air-lines-stock-rockets-after-ceo-predicts-2025-as-best-financial-year/chGW8e7RZt">Delta Air Lines Stock Rockets After CEO Ed Bastian Projects 2025 As Best Ever Financial Year: Retail Sentiment Flies To Year-High</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

n this photo illustration, American Express Global Business Travel (AmEx GBT) is seen displayed on a smartphone and in the background. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Global Business Travel Group Stock Falls On DOJ’s Lawsuit To Block Acquisition Of CWT Holdings

DOJ’s lawsuit alleges that the proposed transaction would impact competition for business travel management services to U.S. global and multinational businesses.

DOJ’s lawsuit alleges that the proposed transaction would impact competition for business travel management services to U.S. global and multinational businesses. Notably, this is Amex GBT’s fifth acquisition of another travel management company since 2018.

Wolfspeed Inc. (WOLF) stock plunged over 11% on Friday, hitting a historic low of $5.11—the lowest price since October 1998.&nbsp;Despite the steep decline, retail sentiment on Stocktwits remained bullish, with many users advocating for buying the dip.The broader semiconductor sell-off was fueled by a Bloomberg report detailing the Biden administration's&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvda-avgo-amd-stocks-fall-on-biden-chip-export-restrictions-report/chGWAcMRZw">impending export restrictions on chips</a>. These measures, set to be finalized before Biden’s term ends, aim to curb AI chip access for countries like China and Russia.Wolfspeed's troubles, however, run deeper.&nbsp;The stock has plummeted over 85% in the past&nbsp;12 months,&nbsp;dragged down by disappointing financial results, management struggles, and legal woes.&nbsp;In December, a report by Axios highlighted the company's challenges in scaling its silicon carbide (SiC) chips business, compounded by multiple class-action lawsuits alleging securities fraud.The lawsuits stem from Wolfspeed’s announcement of first-quarter FY25 results on November 6, which revealed lower-than-expected guidance for the second quarter.The company admitted to slower-than-anticipated demand and delayed EV customer timelines.&nbsp;Plaintiffs argue that these developments starkly contradicted earlier claims that its Mohawk Valley fabrication facility would generate $100 million in revenue at 20% utilization, leading to a drop in&nbsp;<a href="https://stocktwits.com/symbol/WOLF">Wolfspeed’s stock</a> price, and massive losses.<figure class="image"><img style="aspect-ratio:1288/296;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_01_10_115830_72d45de74b.png" alt="Screenshot 2025-01-10 115830.png" width="1288" height="296"><figcaption>Wolfspeed Inc. Sentiment and Message Volume on Jan.10 as of 12:00 p.m. ET | Source: Stocktwits</figcaption></figure>Despite the bear run, retail sentiment on Stocktwits around Wolfspeed’s shares was ‘bullish’ with chatter dipping marginally to ‘high’ from ‘extremely high’ levels a day ago.&nbsp;Many users on the platform recommended using the opportunity to buy up more shares.&nbsp; <stembedurl>https://stocktwits.com/Robcat/message/599520465</stembedurl><stembedurl>https://stocktwits.com/Truth911/message/599572303</stembedurl><stembedurl>https://stocktwits.com/springi/message/599569545</stembedurl>One user speculated that the sell-off could involve factors beyond bearish sentiment, hinting at deeper market dynamics.<stembedurl>https://stocktwits.com/Zeck/message/599573973</stembedurl>Wolfspeed had transitioned from its lighting business to focus on SiC semiconductors, which are integral to some electric vehicles (EVs).&nbsp;While the pivot initially boosted the stock, delays in EV adoption and intensifying competition from Chinese firms have since eroded investor confidence.The stock's future outlook also looks bleak on Wall Street, with analysts warning of potential headwinds from Donald Trump’s presidential victory, which could spell the end of the $7,500 EV tax credit.&nbsp;According to a research note from Mizuho after the November election, reduced subsidies might slow EV production, impacting SiC demand and Wolfspeed's growth trajectory.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/amd-stock-hits-one-year-low-goldman-sachs-downgrade-rising-competition/chGW8sZRZu">AMD Stock Hits Over One-Year Low Amid Rising Competition, Analyst Downgrades: Retail Loses Patience</a>

Retail Sentiment On Wolfspeed Stock Remains Bullish Despite Historic Drop To 27-Year Low

Wolfspeed stock falls to its lowest level since 1998 amid broader semiconductor sector sell-off, but retail optimism persists on Stocktwits.

Novavax Inc. had an impressive 2024, with its stock gaining nearly 68%. The momentum has continued into 2025, with shares up over 11% year-to-date.&nbsp;Despite recent challenges, retail investors remain optimistic, viewing the stock as undervalued at current levels.The stock has seen heightened attention on Stocktwits,&nbsp;boasting over 102,000 followers — making it the third-most-followed biotech ticker.&nbsp;Message volume on the platform has surged by over 1,200% since the&nbsp;beginning of the year, reflecting growing retail interest.Novavax faced setbacks late last year when the FDA placed its COVID-19 and influenza combination vaccine (CIC) on clinical&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvax-stock-falls-after-fda-clinical-hold-on-vaccine-candidates/cJczdHnR4y">hold</a> due to a safety concern during trials.&nbsp;That hold was lifted within a month, allowing the company to resume development. However, reduced annual revenue guidance during positive third-quarter&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/novavax-q3-loss-revenue-beat-estimates/cJ40GHcROS">earnings</a>&nbsp;tempered investor enthusiasm.On the positive side, Novavax&nbsp;<a href="https://stocktwits.com/news-articles/markets/5/nvax-hits-first-milestone-in-sanofi-partnership/cJa9seMRKI">achieved</a> a key milestone in December under its partnership with Sanofi, earning $50 million for progress in a phase 2/3 trial of a COVID-19 vaccine for children.&nbsp;The collaboration holds potential for up to $650 million in additional milestone payments, along with tiered royalties.In a recent Stocktwits poll, 67% of retail investors deemed the stock undervalued, while 24% were awaiting more clarity or avoiding it.&nbsp;<figure class="image"><img style="aspect-ratio:1316/746;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/NVAX_poll_and_results_0807297c32.png" alt="NVAX poll and results.png" width="1316" height="746"><figcaption>NVAX poll and results | source: Stocktwits</figcaption></figure>Retail chatter remains mostly optimistic on Stocktwits, with some investors eyeing a return beyond the $100 mark — a level last seen in February 2022 as the COVID-19 pandemic was starting to ease. The stock now trades 91% below those highs.Bullish watchers pinned hopes on Novavax’s $909.5 million cash position, relatively low debt of $262 million, and ongoing COVID-19 vaccine sales across Europe as reasons for confidence.&nbsp;<stembedurl>https://stocktwits.com/fofom/message/599515059</stembedurl><stembedurl>https://stocktwits.com/Serking/message/599493090</stembedurl><stembedurl>https://stocktwits.com/cuttheknot/message/599572197</stembedurl>CEO John Jacobs has also emphasized plans to diversify beyond COVID-19 and influenza with a pipeline that includes standalone influenza candidates and proprietary technology used in some malaria vaccines.Investors are also awaiting updates on the company’s&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/mrna-nvax-stocks-rise-amid-bird-flu-concerns/chGIRrpRmm">bird flu</a> vaccine candidates, which have reportedly been through pre-clinical trials, as rising U.S. cases cause concerns.Despite challenges, Novavax’s cash reserves and promising partnerships position it as a compelling prospect for long-term investors.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a medical syringe is displayed on a screen, and the logo of Novavax in the background. (Photo Illustration by Nikos Pekiaridis/SOPA Images/LightRocket via Getty Images)

We Asked Retail If Novavax Stock Is A Buy At Current Levels: Nearly 70% Think It's Undervalued

Message volume on Stocktwits has surged by over 1,200% since the beginning of the year, reflecting growing interest.

Retail Investors See Novavax Stock As Undervalued Despite Recent Challenges 

Shares of Intel Corp. (INTC) fell to a five-month low on Friday after analysts at Mizuho lowered their price target for the chipmaker’s stock.At the time of writing, <a href="https://stocktwits.com/symbol/INTC">Intel's share price</a> was down nearly 4.6%, hovering around $18.96, a level last seen in September.According to TheFly, Mizuho lowered its price target for Intel from $23 to $21 – a level Intel was last trading at in August last year – while maintaining a rating of ‘neutral.’Apart from Mizuho’s price target reduction, another factor impacting Intel’s stock price on Friday is President Joe Biden’s <a href="https://stocktwits.com/news-articles/markets/equity/nvda-avgo-amd-stocks-fall-on-biden-chip-export-restrictions-report/chGWAcMRZw">reported plan to announce more chip export restrictions</a>.Intel’s stock has been battered for a while now – it is currently at the level it was at nearly 22 years ago. The chipmaker has been trying to turn around its fortunes for years now, and bringing back Pat Gelsinger was an attempt undertaken in the same vein.However, with Gelsinger now out and Qualcomm Inc. (QCOM) having reportedly dropped its plans to acquire Intel, the chipmaker is waiting for a new captain to steer the ship.Meantime, analysts at Citi maintained their ‘Neutral’&nbsp;rating but added that they expect Intel to hire a new CEO in a “couple of months,” according to a note seen <a target="_blank" rel="noopener noreferrer nofollow" href="https://seekingalpha.com/news/4393827-intel-could-announce-new-ceo-in-a-couple-of-months-citi-says">by</a> SeekingAlpha.However,&nbsp;retail sentiment on Stocktwits&nbsp;was exuberant, turning ‘extremely bullish’ (81/100) from ‘bearish’ (37/100) a day ago. Message volume also witnessed a spike, rising to ‘high’ (62/100) from ‘normal’ (49/100)&nbsp;levels.<figure class="image"><img style="aspect-ratio:645/150;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_01_10_222312_f51a238325.jpg" alt="INTC retail sentiment" width="645" height="150"><figcaption>INTC sentiment and message volume January 10, 2025, as of 11:45 am ET | Source: Stocktwits</figcaption></figure>One user&nbsp;said&nbsp;it’s now or never as far as buying the Intel stock is concerned.<stembedurl>https://stocktwits.com/gl47leilui/message/599569638</stembedurl><stembedurl>https://stocktwits.com/iNvest4Win/message/599566828</stembedurl>Another user&nbsp;commented the stock is “oversold.”<stembedurl>https://stocktwits.com/ss1983/message/599568308</stembedurl><stembedurl>https://stocktwits.com/JDKING/message/599566093</stembedurl>Not everyone is sold on the bullish sentiment, though.<stembedurl>https://stocktwits.com/YouYoloOnlyOnce/message/599569210</stembedurl>Intel stock price has fallen by more than 45% in the past six months, while its one-year decline is worse, at nearly 60%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/constellation-energy-surges-pre-market-as-it-agrees-to-buy-calpine-in-266b-deal/chGW8mHRZM">Constellation Energy Surges Pre-Market On $26.6B Calpine Acquisition Deal: Retail Sees Spark</a>

The Intel logo can be seen at the headquarters of the chip company

Intel Stock Hits 5-Month Low As Mizuho Lowers Price Target, Citi Stays 'Neutral' As Investors Await Pat Gelsinger's Replacement: Retail Turns Bullish

Intel’s stock has been battered for a while now – it is currently at the level it was at nearly 22 years ago. The chipmaker has been trying to turn around its fortunes for years now.

Paychex Inc (PAYX) shares were in the spotlight on Friday after the firm <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20250110481962/en/Paychex-Declares-Quarterly-Dividend">declared</a> its quarterly dividend. The company, which provides advisory services in human resources, employee benefits solutions, insurance, and payroll, announced a regular quarterly cash dividend of $0.98 per share on its common stock.The dividend is consistent with what the firm has paid in the previous three quarters. It is payable on Feb. 27, 2025, to shareholders of record as of Feb. 7, 2025.Despite the announcement, shares of the firm were trading nearly 1% lower on Friday.On Stocktwits, retail sentiment flipped into the ‘extremely bullish’ territory (80/100) from ‘neutral’ a week ago. The move was accompanied by a ‘high’ message volume.<figure class="image"><img style="aspect-ratio:1868/430;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_01_10_at_11_11_53_AM_2303eff2f3.png" alt="PAYX’s Sentiment Meter and Message Volume as of 10:41 a.m. ET on Jan. 10, 2025 | Source: Stocktwits" width="1868" height="430"><figcaption>PAYX’s Sentiment Meter and Message Volume as of 10:41 a.m. ET on Jan. 10, 2025 | Source: Stocktwits</figcaption></figure>The company has been in the news lately after it signed a definitive agreement to acquire Paycor HCM, Inc. (PYCR), a provider of human capital management (HCM), payroll, and talent software, in an all-cash transaction for $22.50 per share.The price represents an enterprise value of approximately $4.1 billion. According to Paychex, the acquisition significantly expands its sales coverage and adds additional growth platforms through its access to Paycor’s strategic partnerships and embedded HCM capabilities.Paychex expects run-rate cost synergies over $80 million in the near term and significant revenue synergy opportunities over the next several years.&nbsp;&nbsp;&nbsp;&nbsp;Meanwhile, the firm reported earlier this week that job growth in U.S. small businesses with fewer than 50 employees averaged modest employment growth throughout 2024, according to the Paychex Small Business Employment Watch.“At 2.96% in December, hourly earnings growth for U.S. small business workers remained below three percent for the fifth consecutive month,” the firm said.Meanwhile, <a href="https://stocktwits.com/symbol/PAYX">Paychex shares</a> have gained over 17% over the past year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/delta-air-lines-stock-rockets-after-ceo-predicts-2025-as-best-financial-year/chGW8e7RZt">Delta Air Lines Stock Rockets After CEO Ed Bastian Projects 2025 As Best Ever Financial Year: Retail Sentiment Flies To Year-Hig</a>hFor updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Paychex company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Paychex Stock Falls After Firm Announces $0.98 Quarterly Dividend: But Retail Goes Extremely Bullish

The dividend is payable on Feb. 27, 2025, to shareholders of record as of Feb. 7, 2025.

SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

iShares Russell 2000 ETF

ARK Innovation ETF

Bitcoin

Ripple

Cardano

SHIRO

Stellar Lumens

ECO AI

Old Dominion Freight Line, Inc.

Benqi Finance

Berkshire Hathaway Inc.

Velo Labs

Binance

Intra-Cellular Therapies Inc

Leidos Holdings Inc

Berkshire Hathaway Inc

Bicycle Therapeutics Plc - ADR

Hedera Hashgraph

Nestle SA ADR

Assemble Protocol

SNEK

MXC Foundation

XinFin Network

Safemoon V2

Madrigal Pharmaceuticals Inc

BONE SHIBASWAP

ETF Series Solutions Trust - ESS U.S.Global Jets ETF

GraniteShares ETF Trust - GraniteShares YieldBOOST TSLA ETF

WEIBO

Waste Connections Inc

Signet Jewelers Ltd

Stride Inc

Beazer Homes USA Inc.

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


News